Search Results | Cancer Research | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Abstract 845: Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis

Sirkku Pollari, Rami Käkönen, Khalid S. Mohammad, Jukka P. Rissanen, Jussi Halleen, Anni Wärri, Liisa Nissinen, Marjo Pihlavisto, Anne Marjamäki, Merja Perälä, Theresa Guise, Olli Kallioniemi, Sanna-Maria Käkönen

Cancer Res (2011) 71 (8_Supplement): 845.

DOI: https://doi.org/10.1158/1538-7445.AM2011-845

Published: 15 April 2011

View article

Journal Articles

Abstract 5394: Sequential treatment with zoledronic acid and doxorubicin has no additive effects in an established mouse model of bone metastasis

Mari I. Suominen, Rami Käkönen, Jukka P. Rissanen, Sanna-Maria Käkönen, Jussi M. Halleen

Cancer Res (2010) 70 (8_Supplement): 5394.

DOI: https://doi.org/10.1158/1538-7445.AM10-5394

Published: 15 April 2010

View article

Journal Articles

Abstract LB-144: In vivo detection of bone metastases in a mouse model by positron emission tomography (PET) with [F-18]-labeled tyrosine derivative (D-FMT)

Sabine Zitzmann-Kolbe, Anne Strube, Anna-Lena Frisk, Sanna-Maria Käkönen, Hideo Tsukada, Peter Hauff, Dietmar Berndorff, Volker Gekeler, Keith Graham

Cancer Res (2010) 70 (8_Supplement): LB-144.

DOI: https://doi.org/10.1158/1538-7445.AM10-LB-144

Published: 15 April 2010

View article

Journal Articles

Synergistic effects on tumor growth inhibition by the combination of ZK 304709, the Multi-target Tumor Growth Inhibitor™, and paclitaxel or 5-FU in a mammary tumor xenograft model

Sanna-Maria Käkönen, Candice McCoy, Debra Hyman, Ulrich Lücking, Klaus Bosslet, Gerhard Siemeister

Cancer Res (2006) 66 (8_Supplement): 951.

Published: 15 April 2006

View article

Journal Articles

The antitumor and antimetastasis effect of the oral Multi-target Tumor Growth Inhibitor™, ZK 304709, in pancreatic tumor xenografts

Gerhard Siemeister, Katharina Detjen, Sanna-Maria Käkönen, Ulrich Lücking, Domink Mumberg, Arne Scholz, Karola Wagner, Bertram Wiedenmann, Klaus Bosslet

Cancer Res (2006) 66 (8_Supplement): 951.

Published: 15 April 2006

View article

Journal Articles

RNA interference profiles, gene expression, and copy number changes in bone metastatic breast cancer cells: an integrated molecular and functional screening

Sirkku Pollari, Merja Perälä, Saija Haapa-Paananen, Niko Sahlberg, Kirsi Ojala, Pekka Tiikkainen, Maija Wolf, Henrik Edgren, Jukka Rissanen, Jussi Halleen, Sanna-Maria Käkönen, Olli-P. Kallioniemi

Cancer Res (2006) 66 (8_Supplement): 978.

Published: 15 April 2006

View article

NARROW

Abstract 845: Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis

Abstract 5394: Sequential treatment with zoledronic acid and doxorubicin has no additive effects in an established mouse model of bone metastasis

Abstract LB-144: In vivo detection of bone metastases in a mouse model by positron emission tomography (PET) with [F-18]-labeled tyrosine derivative (D-FMT)

Synergistic effects on tumor growth inhibition by the combination of ZK 304709, the Multi-target Tumor Growth Inhibitor™, and paclitaxel or 5-FU in a mammary tumor xenograft model

The antitumor and antimetastasis effect of the oral Multi-target Tumor Growth Inhibitor™, ZK 304709, in pancreatic tumor xenografts

RNA interference profiles, gene expression, and copy number changes in bone metastatic breast cancer cells: an integrated molecular and functional screening

Email alerts

AACR Journals

Abstract 845: Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis

Abstract 5394: Sequential treatment with zoledronic acid and doxorubicin has no additive effects in an established mouse model of bone metastasis

Abstract LB-144: In vivo detection of bone metastases in a mouse model by positron emission tomography (PET) with [F-18]-labeled tyrosine derivative (D-FMT)

Synergistic effects on tumor growth inhibition by the combination of ZK 304709, the Multi-target Tumor Growth Inhibitor™, and paclitaxel or 5-FU in a mammary tumor xenograft model

The antitumor and antimetastasis effect of the oral Multi-target Tumor Growth Inhibitor™, ZK 304709, in pancreatic tumor xenografts

RNA interference profiles, gene expression, and copy number changes in bone metastatic breast cancer cells: an integrated molecular and functional screening

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only